サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：羊水穿刺針の世界市場-2022-2029
市場調査レポート
商品コード
1169016

羊水穿刺針の世界市場-2022-2029

Global Amniocentesis Needles Market - 2022-2029
出版日: | 発行: DataM Intelligence | ページ情報: 英文 200 Pages | 納期: 約2営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
羊水穿刺針の世界市場-2022-2029
出版日: 2022年12月08日
発行: DataM Intelligence
ページ情報: 英文 200 Pages
納期: 約2営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

市場概要

羊水穿刺針の世界市場規模は、予測期間（2022-2029年）にCAGR4.2％で成長すると予測されています。

羊水穿刺針は、検査や治療のために子宮から羊水や細胞を取り出す羊水穿刺の処置に利用されるものです。妊娠中、赤ちゃんは羊水に包まれ、守られています。赤ちゃんの健康に関する情報は、羊水穿刺によって決定されます。

市場力学

羊水穿刺針の世界市場を牽引する主な要因は、世界の出産件数の増加と、ダウン症や感染症などの致命的な遺伝子疾患に関する人々の意識です。新製品発売の増加は、羊水穿刺針市場の成長に寄与しています。

出産数の増加や羊水穿刺法の採用の増加は、市場の成長を促進すると予想されます。

遺伝性疾患、胎児肺検査、感染症診断のための羊水穿刺手順の採用の増加、妊娠数の増加、新規製品発売数の増加が羊水穿刺針市場を牽引しています。また、出産数の増加も市場の成長を後押ししています。多くのヘルスケア企業が新製品を開発するために、研究開発活動を活発化させています。

羊水穿刺針は、遺伝子検査、胎児輸血、胎児肺検査、羊水減少処置、多水膜症治療、経皮的臍帯サンプリング、胎児感染症診断など、さまざまな用途で使用されています。これらのアプリケーションは、乳幼児の遺伝性疾患の増加により、世界的に市場が拡大しています。さらに、主要プレイヤーによる技術的に高度な製品の提供も、市場の成長に重要な役割を果たすと予想されます。

機器に関連するリスクと高コストが市場成長の妨げになると予想されます。

羊水穿刺後に少量の羊水が膣から漏れ出す羊水漏出などのリスクがいくつか存在します。これはまれなケースで、妊娠に影響することはありません。針刺し事故は、赤ちゃんが自分の足や腕を針の軌道に乗せてしまい、怪我をする危険性があります。

妊娠中期に、経験豊富な人が超音波の助けを借りて羊水穿刺を行う場合、流産の危険性が少しあります。尿毒症の引き金になることがあります。Rh感作も、赤ちゃんの血液細胞が母親の血流に入ることで起こる合併症です。Rh陰性の母親にはRh免疫グロブリンを注射し、母親の体が赤ちゃんの血液細胞にダメージを与える可能性のあるRh抗体を作らないようにします。

COVID-19の影響分析

パンデミックは、世界の財務的な期待、オペレーション、危機対応戦略にマイナスの影響を与えています。COVID-19の発生は、ヘルスケア産業に深刻な影響を及ぼしています。羊水穿刺針市場は、COVIDの症例増加により、様々な研究や臨床試験が本格的に開始されたため、COVIDによる巨額の損失を経験しました。様々な取り組み、製品の発売、技術革新、コラボレーション、合併が世界中で起こっており、市場の成長を後押ししています。例えば、2021年4月、メダックスSRLはインドでMedOne UltraとMedEasyの製品化を発表しました。

目次

第1章 調査手法と調査範囲

  • 調査手法
  • 調査目的および調査範囲

第2章 市場の定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

  • 市場影響要因
    • 促進要因
      • 出産の増加
      • 妊婦の糖尿病罹患率の増加
      • 羊水穿刺の普及率上昇
    • 抑制要因
      • 羊水穿刺の高いコスト
      • 合併症または感染症
      • 代替品の利用可能性
    • ビジネスチャンス
    • 影響分析

第5章 産業分析

  • ポーターのファイブフォース分析
  • サプライチェーン分析
  • プライシング分析

第6章 COVID-19の分析

  • COVID-19の市場分析
    • COVID-19以前の市場シナリオ
    • COVID-19の現在の市場シナリオ
    • COVID-19の後、または将来のシナリオ
  • COVID-19の中での価格ダイナミクス
  • 需要-供給スペクトラム
  • パンデミック時の市場に関連する政府の取り組み
  • メーカーの戦略的取り組み
  • まとめ

第7章 製品タイプ別

  • 100-150mm
  • 150mm超
  • 100mm未満

第8章 アプリケーション別

  • 羊水穿刺
  • 遺伝子検査
  • 胎児輸血
  • 胎児肺活量検査
  • 羊水分解処置
  • 多飲症治療
  • 経皮的臍帯サンプリング
  • 胎児感染症診断

第9章 エンドユーザー別

  • 病院
  • 診断センター
  • 専門クリニック
  • その他

第10章 地域別

  • 北米
    • 米国
    • カナダ
    • メキシコ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • イタリア
    • スペイン
    • その他欧州
  • 南米
    • ブラジル
    • アルゼンチン
    • その他の南米地域
  • アジア太平洋地域
    • 中国
    • インド
    • 日本
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ地域

第11章 競合情勢

  • 主な展開と戦略
  • 企業シェア分析
  • 製品ベンチマーク
  • 注目の主要企業リスト

第12章 企業プロファイル

  • Cooper Surgical Inc.
    • 企業概要
    • 製品ポートフォリオと説明
    • 主なハイライト
    • 財務概要
  • Cook
  • ICU Medical Inc.
  • Biopsybell
  • Becton, Dickinson and Company
  • Medline Industries LP
  • RI. MOS. Srl
  • Laboratoire CCD
  • Rocket Medical Plc
  • Medax Srl

第13章 羊水穿刺針の世界市場-DataM

目次
Product Code: DMMD1224

Market Overview

The global amniocentesis needles market size was valued at US$ XX million in 2022 and is estimated to reach US$ XX million by 2029, growing at a CAGR of 4.2% during the forecast period (2022-2029).

The amniocentesis needles are utilized for the amniocentesis procedure in which amniotic fluid or cells are removed for testing and treatment from the uterus. The baby is surrounded and protected by amniotic fluid during the pregnancy. Information regarding the baby's health can be determined via amniocentesis.

Market Dynamics

The major factors driving the global amniocentesis needles market are an increase in the number of childbirths across the globe and awareness among the population regarding fatal genetic disorders such as down's syndrome or infections. An increase in novel product launches contributes to the growth of the amniocentesis needles market.

The increasing number of childbirths and increasing adoption of amniocentesis procedures are expected to drive the market's growth.

The rising adoption of amniocentesis procedures for genetic disorders, fetal lung testing and infection diagnosis, an increase in pregnancies, and the rising number of novel product launches drive the amniocentesis needles market. An increase in the number of childbirths is also aiding the market growth. There has been an increase in R&D activities by many healthcare companies to develop novel products.

Amniocentesis needles are used in various applications such as genetic testing, fetal blood transfusion, fetal lung testing, amnioreduction procedure, polyhydramnios treatment, percutaneous umbilical cord sampling, and fetal infection diagnosis. The market for these applications is increasing worldwide due to the increasing number of infant genetic disorders. Moreover, the availability of technologically advanced products by key players is also expected to play a vital role in the market's growth.

Various novel product launches and research studies contribute to the market's growth. For instance, in January 5, 2021, Cooper Surgical, a women's healthcare solution provider, announced its acquisition of Embryo Options, a cryo-storage solutions provider. This acquisition enhances Cooper's innovative fertility product portfolio.

The risks associated with these devices and the high cost are expected to hamper the market's growth.

However, there are several risks faced by the minor population, such as leakage of amniotic fluid in which, after amniocentesis small amount of amniotic fluid starts leaking through the vagina. This is rare and doesn't affect pregnancy. Needle injury is another risk where the baby might bring its leg or arm in the path of the needle that, causes injury.

During the second trimester, there is a little risk of miscarriage in the amniocentesis procedure if done by an experienced person with the help of ultrasound. It can trigger a urine infection. Rh sensitization is also a complication when a baby's blood cells enter the mother's bloodstream. Rh-negative mother is given Rh immunoglobulin injection to prevent the mother's body from making Rh antibodies that can cause damage to the blood cells of the baby.

COVID-19 Impact Analysis

The pandemic has negatively impacted global financial expectations, operations and crisis response strategy. The COVID-19 outbreak has severely impacted the healthcare industry. The amniocentesis needles market has experienced huge losses due to COVID, as various research and clinical trials started in full swing due to the increasing cases of COVID. Various initiatives, product launches, innovations, collaborations and mergers are happening worldwide, boosting the market's growth. For instance, in Apr 2021, Medax SRL announced the commercialization of MedOne Ultra and MedEasy in India.

Segment Analysis

The amniocentesis segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The amniocentesis segment is the largest market shareholder due to its high demand, increasing childbirth and rising adoption of amniocentesis procedures.

A prenatal test named amniocentesis is done for genetic disorders diagnosis. Genetic disorders, including spina bifida and down syndrome and other fetus health issues. Amniocentesis needles are used for amniotic fluid removal in a small amount from the uterus. The lab then tests the amniotic fluid sample for various genetic or chromosomal conditions. This procedure is done during the second or third trimester of pregnancy.

The growing number of regulatory approvals, technological advancements, product launches, and research/clinical trial studies drive the market's growth. For instance, MRD SRL's Amnio needle is a novel stainless steel cannula needle that is disposable and is used for amniotic fluid transabdominal sampling for prenatal diagnosis of the fetus, such as genetic disorders known as amniocentesis. This needle has an echogenic marker that supports correct needle placement in ultrasound guidance. Adjustable stoppers and centimeter markings help to determine the insertion depth.

Geographical Analysis

North America holds the largest market share in the global amniocentesis needles market.

North America dominates the global amniocentesis needles market, primarily due to its large population combined with excellent medical infrastructure and the rising number of childbirth and pregnancies. According to National Centre for Health, in 2022, cancer was the second leading cause of mortality worldwide, with around 1,918,030 new cases registered 2022. Cancer was responsible for 609,360 deaths all over the world. Moreover, as per WHO, the number of new cases is expected to rise by around 70% by 2030.

Increasing expenditure on healthcare and raising awareness among people is also contributing to the market's growth in this region. Advancement of applications of amniocentesis needles in amniocentesis procedures and prenatal diagnostics, such as genetic disorders and fatal infections, increase in pharmaceutical establishment across the region and government approvals, and the presence of key players in the region are contributing to the growth of the amniocentesis needles market.

Moreover, the growing number of product launches is responsible for the market's growth. Many key developments, technological advancements, collaborations, and agreements are taking place in this region. For instance, in Jan 6, 2022, ICU Medical Inc., announced it had completely acquired Smiths Medical from the Smith's Group. Smith's Medical business such as syringes, vital care and vascular access products, and ambulatory infusion devices.

Competitive Landscape

The amniocentesis needles market is moderately competitive with local and global companies' presence. Cooper Surgical Inc., Cook, ICU Medical Inc., Biopsybell, Becton, Dickinson and Company, Medline Industries LP, RI. MOS. Srl, Laboratoire CCD, Rocket Medical Plc, Medax Srl and more. The key players are adopting various growth strategies such as product launches, mergers & acquisitions, partnerships, and collaborations, contributing to the market's growth. For instance, in Dec 17, 2021, Cooper Companies announced its completion of an acquisition agreement with Generate Life Sciences, a donor egg and sperm provider for fertility treatment and stem cell storage of newborns (cord tissue and blood).

Cooper Surgical Inc.

Overview: Cooper Surgical is a medical device company that focuses on women's and babies' health advancements with its wide products and services portfolio on fertility and genomics, and medical devices. It was established in 1990 and is headquartered in Connecticut, United States.

Product Portfolio:

Wallace Amniocentesis Needles: Wallace is an amniocentesis single-use needle that is provided in sterile packs for the sampling of amniotic fluid. The tip of the needle contains spiral engraving that offers clear visibility.

The global amniocentesis needles market report would provide access to approx. 45 + market data tables, 40 + figures and 200 (approximate) pages.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

4. Market Dynamics

  • 4.1. Market Impacting Factors
    • 4.1.1. Drivers
      • 4.1.1.1. Increasing Childbirth
      • 4.1.1.2. Prevalence of Diabetes in the Pregnant Woman
      • 4.1.1.3. Increasing Adoption of Amniocentesis Procedures.
    • 4.1.2. Restraints:
      • 4.1.2.1. High Cost of Amniocentesis Procedures
      • 4.1.2.2. Complications or Infections
      • 4.1.2.3. Availability of Substitutes
    • 4.1.3. Opportunity
    • 4.1.4. Impact Analysis

5. Industry Analysis

  • 5.1 Porter's Five Forces Analysis
  • 5.2 Supply Chain Analysis
  • 5.3 Pricing Analysis

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During the Pandemic
  • 6.5. Manufacturer's Strategic Initiatives
  • 6.6. Conclusion

7. By Product Type

  • 7.1. Introduction
    • 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 7.1.2. Market Attractiveness Index, By Product Type
  • 7.2. 100-150mm *
    • 7.2.1. Introduction
    • 7.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 7.3. Larger than 150mm
  • 7.4. Smaller than 100mm

8. By Application

  • 8.1. Introduction
    • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 8.1.2. Market Attractiveness Index, By Application
  • 8.2. Amniocentesis *
    • 8.2.1. Introduction
    • 8.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 8.3. Genetic testing
  • 8.4. Fetal Blood Transfusion
  • 8.5. Fetal Lung Testing
  • 8.6. Amnioreduction Procedure
  • 8.7. Polyhydramnios Treatment
  • 8.8. Percutaneous Umbilical Cord Sampling
  • 8.9. Fetal Infection Diagnosis

9. By End-User

  • 9.1. Introduction
    • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 9.1.2. Market Attractiveness Index, By End-User
  • 9.2. Hospitals *
    • 9.2.1. Introduction
    • 9.2.2. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  • 9.3. Diagnostic Centers
  • 9.4. Specialty Clinics
  • 9.5. Others

10. By Region

  • 10.1. Introduction
    • 10.1.1. Market Size Analysis US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
    • 10.1.2. Market Attractiveness Index, By Region
  • 10.2. North America
    • 10.2.1. Introduction
    • 10.2.2. Key Region-Specific Dynamics
    • 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.2.6.1. U.S.
      • 10.2.6.2. Canada
      • 10.2.6.3. Mexico
  • 10.3. Europe
    • 10.3.1. Introduction
    • 10.3.2. Key Region-Specific Dynamics
    • 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.3.6.1. Germany
      • 10.3.6.2. U.K.
      • 10.3.6.3. France
      • 10.3.6.4. Italy
      • 10.3.6.5. Spain
      • 10.3.6.6. Rest of Europe
  • 10.4. South America
    • 10.4.1. Introduction
    • 10.4.2. Key Region-Specific Dynamics
    • 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.4.6.1. Brazil
      • 10.4.6.2. Argentina
      • 10.4.6.3. Rest of South America
  • 10.5. Asia Pacific
    • 10.5.1. Introduction
    • 10.5.2. Key Region-Specific Dynamics
    • 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
    • 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
      • 10.5.6.1. China
      • 10.5.6.2. India
      • 10.5.6.3. Japan
      • 10.5.6.4. Australia
      • 10.5.6.5. Rest of Asia Pacific
  • 10.6. Middle East and Africa
    • 10.6.1. Introduction
    • 10.6.2. Key Region-Specific Dynamics
    • 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
    • 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
    • 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User

11. Competitive Landscape

  • 11.1. Key Developments and Strategies
  • 11.2. Company Share Analysis
  • 11.3. Products Benchmarking
  • 11.4. List of Key Companies to Watch

12. Company Profiles

  • 12.1. Cooper Surgical Inc. *
    • 12.1.1. Company Overview
    • 12.1.2. Product Portfolio and Description
    • 12.1.3. Key Highlights
    • 12.1.4. Financial Overview
  • 12.2. Cook
  • 12.3. ICU Medical Inc.
  • 12.4. Biopsybell
  • 12.5. Becton, Dickinson and Company
  • 12.6. Medline Industries LP
  • 12.7. RI. MOS. Srl
  • 12.8. Laboratoire CCD
  • 12.9. Rocket Medical Plc
  • 12.10. Medax Srl

LIST NOT EXHAUSTIVE

13. Global Amniocentesis Needles Market - DataM

  • 13.1. Appendix
  • 13.2. About Us and End-User
  • 13.3. Contact Us